TLN-372 in Advanced KRAS Mutant Solid Tumors

Clinical trial NCT07204340 · RECRUITING

Trial details

NCT number: NCT07204340
Sponsor: Treeline Biosciences, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

KRAS Mutant Solid Tumors

Start date: 2025-09-29
Primary completion: 2031-12-03
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.